Sara Coon

Sara Coon has extensive work experience in regulatory affairs and quality assurance within the medical device industry. Sara is currently the Director of Regulatory Affairs - Devices at Halozyme, Inc. Prior to this role, they served as the Director of Regulatory Affairs at Antares Pharma Inc. from 2019 to 2022, and as the Associate Director of Regulatory Affairs - Devices from 2016 to 2019. Sara also worked as a QA Manager at Formacoat, LLC from 2007 to 2016. Before that, they held various regulatory affairs positions at companies such as Alquest, Inc., Boston Scientific, Vascular Solutions, American Medical Systems, AGA Medical, and Lifecore Biomedical.

Sara Coon has a Bachelor of Science (BS) degree in Biology from Iowa State University. In addition to their degree, they have obtained several certifications including the ASQ Certified Quality Auditor from ASQ - World Headquarters in 2007, the RAC-US certification from the Regulatory Affairs Certification Program in December 2000, and they are a member of RAPS (Regulatory Affairs Certification Program) since February 2000. Sara also holds a certification called RAC from the Regulatory Affairs Professionals Society (RAPS), but specific details regarding its acquisition are not provided.